Zydus Lifesciences: India’s Pharma Powerhouse on a Global Growth Spree
Zydus Lifesciences, one of India’s leading pharmaceutical giants, continues to redefine innovation, growth, and healthcare solutions both at home and abroad. From life-saving drug launches to international expansions and soaring profits, the company is setting benchmarks for the entire pharma industry. 📈 FY24: A Year of Big Wins In FY 2023-24 , Zydus posted an impressive 97% rise in consolidated net profit , touching ₹3,859.5 crore , nearly doubling from the previous year's ₹1,960.3 crore. This spike was driven by strong demand in both Indian and US markets , and its shares reflected the confidence—closing 4.28% higher at ₹1,051.9 on the BSE. 🌍 Going Global: France and Beyond Zydus has now expanded its footprint into France by incorporating a wholly owned subsidiary. This move supports its goal of strengthening its base in Europe , a key market for its specialty and generic drugs. Additionally, the company recently got USFDA approval for two major drugs: Eluxadoline Ta...